2/10/2025

Pyridostigmine Bromide Extended-Release Tablets

Products Affected - Description

- Pyridostigmine bromide oral tablet, Alvogen, 180 mg, bottle, 30 count, NDC 47781-0335-30
- Pyridostigmine bromide oral tablet, Rising Pharmaceuticals, 180 mg, bottle, 30 count, NDC 64980-0220-03

Reason for the Shortage

- Alvogen did not provide a reason for the shortage.
- Bausch Health has Mestinon Timespan available.
- Rising did not provide a reason for the shortage.

Available Products

- Mestinon Timespan oral tablet, Bausch Health, 180 mg, bottle, 30 count, NDC 00187-3013-30

Estimated Resupply Dates

- Alvogen has pyridostigmine bromide 180 mg extended-release tablets on back order and the company cannot estimate a release date.
- Rising has pyridostigmine on back order and the company estimates a release date of mid-February 2025.

Updated

Updated February 10, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 7, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.